URGENT UPDATE: A coalition of 31 Democratic senators has officially launched an investigation into a contentious new policy from the Trump administration that permits the Environmental Protection Agency (EPA) to “disregard” the health impacts of pollution when enacting regulations. This alarming development was confirmed just hours ago, raising significant concerns about public health.
The policy, first uncovered by the New York Times last month, reveals that the EPA plans to cease evaluating the financial value of health benefits derived from controlling fine particulate matter and ozone, focusing solely on the costs to industry. This shift, set to take effect on December 11, 2023, is underpinned by claims that the benefits of reducing emissions are “uncertain.”
In a sharply worded letter directed to EPA Administrator Lee Zeldin, the senators, led by Senator Sheldon Whitehouse, condemned the policy. They asserted, “Even where health benefits are ‘uncertain,’ what is certain is that they are not zero.” The senators warn that this change could lead to dire consequences, including the rejection of measures that could impose only minor costs on polluting industries while saving countless lives.
The implications of this policy adjustment are staggering. Research published in 2023 in the journal Science indicates that PM2.5 pollution from coal-fired power plants alone has claimed approximately 460,000 lives in the U.S. between 1999 and 2020, making it a leading cause of premature death.
Furthermore, the senators highlighted that by ignoring health impacts, the EPA risks costing Americans between $22 and $46 billion in avoided health issues and premature deaths by 2032. In stark contrast, the total compliance cost for industry is projected to be merely $590 million—a fraction of the potential health benefits.
“The Clean Air Act mandates the protection and enhancement of the nation’s air quality,” the senators stated. They emphasized that the current path contradicts the EPA’s own directive to ensure clean air and water, as previously articulated by Zeldin during his confirmation hearing.
The senators have demanded that the EPA provide all documents related to this decision, including cost-benefit analyses and communications with industry stakeholders. They concluded, “EPA may no longer monetize health benefits when setting new clean air standards, but that does not negate their existence. This policy disproportionately favors corporate interests over public welfare.”
As this situation develops, the focus will be on how the EPA responds to the senators’ inquiry and whether public health considerations will take precedence over corporate profit. This investigation could reshape the future of environmental regulations in the U.S., and its effects will be felt across the nation.
Stay tuned for more updates on this critical issue.
